معرفی
Steven Laureys is a Belgian-Canadian neurologist and neuroscientist holding the Canada Excellence Research Chair in Neuroplasticity at the CERVO Brain Centre (Laval University, Canada) since 2024. He also maintains positions as Professor at Laval University's Faculty of Medicine and Research Director at the Belgian National Fund for Scientific Research (FNRS). A pioneer in consciousness studies, Laureys established the Coma Science Group (2006) and GIGA Consciousness Unit (2014) at the University of Liège, Belgium, before co-founding the Hangzhou International Consciousness Institute (2015) and BRAIN-NM Neuromodulation Clinics (2023).
- MD, PhD, Vrije Universiteit Brussel (1993)
- M.Sc. in Pharmaceutical Sciences, VU Brussels (1998)
- PhD in Neurology of Consciousness, University of Liège (2000)
His research focuses on clinical and cognitive neuroscience, particularly disorders of consciousness (coma, vegetative states, locked-in syndrome), neuroplasticity, and neuromodulation therapies. Using multimodal neuroimaging (PET, fMRI, EEG), he investigates brain dynamics during anesthesia, sleep, and meditation while developing novel diagnostic tools and rehabilitation strategies for brain-injured patients.
Scientific Trends across his 450+ publications reveal extensive work on EEG microstate analysis (2025), thalamic firing patterns (2025), and neurostimulation techniques (taVNS, tDCS) for consciousness disorders. His team's 2024-2025 studies emphasize AI-driven consciousness mechanisms, cross-cultural end-of-life decision-making, and z-drug paradoxical effects.
Scientific Recognition includes:
- 2004 - ASSC William James Prize
- 2017 - Francqui Prize (Belgium's highest scientific honor)
- 2024 - Canada Excellence Research Chair ($32M award)
- 2024 - Health 2.0 Outstanding Leadership Award
As Editor-in-Chief of Brain Connectivity (2024), he advances interdisciplinary dialogue between neuroimaging, neurology, and computational science. His translational work bridges basic neuroscience with clinical applications, including co-founding international neuromodulation clinics and leading multicenter trials in traumatic brain injury rehabilitation.
